Morning Market Movers
May 14, 2014 at 09:49 AM EDT
Pernix Therapeutics Holdings (NASDAQ: PTX) shares rose 35.98% to $5.82 following the report of acquisition of US rights for Treximet ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.